Boston acquires RF (radiofrequency) ablation company RadioTherapeutics
This article was originally published in Clinica
Boston Scientific, which has carried out a steady stream of company and technology acquisitions this year, is to buy private company RadioTherapeutics (RTC). The company develops proprietary radiofrequency(RF)-based devices for the ablation of soft tissue lesions. Terms of the deal were not disclosed.